KLK3 and prostate carcinoma: The ability to achieve an undetectable PSA level as nadir is the most significant predictor of the time to CRPC for metastatic and advanced prostatic cancer and the time to nadir PSA is significantly and positively correlated with the PSA progression-free survival [13].